(Q44393540)

English

CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

scientific article published on 11 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

B-cell lymphoma

1 reference

based on heuristic

inferred from title

author name string

N Schmitz

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

S Zeynalova

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

B Glass

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

U Kaiser

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

E Cavallin-Stahl

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Wolf

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Haenel

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Loeffler

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

L Truemper

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Pfreundschuh

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1267-1273

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Response: Intrathecal methotrexate and central nervous system events

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Primary lymphoma of the central nervous system: just DLBCL or not?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Lymphoma dissemination: the other face of lymphocyte homing

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR440

21 January 2018

Identifiers

10.1093/ANNONC/MDR440

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44393540&oldid=2020946964"